These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 28619755)

  • 1. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
    Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
    Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
    Siddiqui MR; Railkar R; Sanford T; Crooks DR; Eckhaus MA; Haines D; Choyke PL; Kobayashi H; Agarwal PK
    Sci Rep; 2019 Feb; 9(1):2084. PubMed ID: 30765854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
    Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
    Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
    Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer.
    Nakamura Y; Ohler ZW; Householder D; Nagaya T; Sato K; Okuyama S; Ogata F; Daar D; Hoa T; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2017 Feb; 16(2):408-414. PubMed ID: 28151706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.
    Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H
    Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
    Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
    Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
    Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
    PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.
    Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
    Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.
    Nagaya T; Gorka AP; Nani RR; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Schnermann MJ; Kobayashi H
    Mol Cancer Ther; 2018 Mar; 17(3):661-670. PubMed ID: 29237807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.
    Kishimoto S; Oshima N; Yamamoto K; Munasinghe J; Ardenkjaer-Larsen JH; Mitchell JB; Choyke PL; Krishna MC
    Free Radic Biol Med; 2018 Feb; 116():1-10. PubMed ID: 29289705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate.
    Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X
    Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700.
    Takao S; Fukushima H; King AP; Kato T; Furusawa A; Okuyama S; Kano M; Choyke PL; Escorcia FE; Kobayashi H
    Cancer Sci; 2023 Dec; 114(12):4654-4663. PubMed ID: 37817415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
    Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
    Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.
    Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H
    BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.
    Moore LS; de Boer E; Warram JM; Tucker MD; Carroll WR; Korb ML; Brandwein-Gensler MS; van Dam GM; Rosenthal EL
    Cancer Med; 2016 Jul; 5(7):1526-34. PubMed ID: 27167827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of conjugate and light dose on photo-immunotherapy induced cytotoxicity.
    Nakajima T; Sato K; Hanaoka H; Watanabe R; Harada T; Choyke PL; Kobayashi H
    BMC Cancer; 2014 May; 14():389. PubMed ID: 24885589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.
    Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Allen C; Kobayashi H
    Mol Cancer Res; 2017 Dec; 15(12):1667-1677. PubMed ID: 28923838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.